Rezolute RZLT
NASDAQ RZLT
$4.60 +0.06 (+1.32%)
As of: Sep 4, 2026 · 2:20 PM EDT

Rezolute (RZLT) EBIT (2012 - 2026)

Rezolute (RZLT) posted EBIT of -$17.4 million for Q1 2026, up 28.3% sequentially from -$24.2 million in Q4 2025, and up 13.27% YoY from -$15.3 million in Q1 2025.

Analysis

Rezolute (RZLT) EBIT (2012 - 2026) Analysis & Trends

Rezolute has reported EBIT for 15 years, with the latest figure at -$17.4 million in Q1 2026.

  • Quarterly EBIT rose 13.27% year-over-year to -$17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$87.3 million (down 13.1% YoY) and the FY2025 annual result came in at -$79.9 million, down 13.45% from the prior year.
  • EBIT advanced to -$17.4 million in Q1 2026 per RZLT's latest filing, from -$24.2 million in the prior quarter.
  • Over five years, EBIT peaked at -$10.2 million in Q3 2022 and troughed at -$25.8 million in Q2 2025.
  • A 5-year average of -$17.0 million and a median of -$16.9 million in 2024 frame the typical range for EBIT.
  • The sharpest annual moves came in 2022 and 2026: EBIT plunged 96.13% in 2022, then climbed 13.27% in 2026.
  • Over 5 years, EBIT stood at -$14.4 million in 2022, then declined by 5.57% to -$15.2 million in 2023, then dropped by 12.41% to -$17.1 million in 2024, then sank by 41.81% to -$24.2 million in 2025, then increased by 28.3% to -$17.4 million in 2026.
  • According to Business Quant data, EBIT over the past three periods registered -$17.4 million, -$24.2 million, and -$19.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -505.13 Mn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 133.12 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -1.55 Mn
10 Rezolute 479.63 Mn 479.63 Mn - -17.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.37 Mn
Dec 31, 2025 -24.22 Mn
Sep 30, 2025 -19.82 Mn
Jun 30, 2025 -25.85 Mn
Mar 31, 2025 -20.02 Mn
Dec 31, 2024 -17.08 Mn
Sep 30, 2024 -16.94 Mn
Jun 30, 2024 -23.10 Mn
Mar 31, 2024 -16.21 Mn
Dec 31, 2023 -15.19 Mn
Sep 30, 2023 -15.91 Mn
Jun 30, 2023 -14.24 Mn
Mar 31, 2023 -17.14 Mn
Dec 31, 2022 -14.39 Mn
Sep 30, 2022 -10.22 Mn
Jun 30, 2022 -11.30 Mn
Mar 31, 2022 -10.75 Mn
Dec 31, 2021 -12.15 Mn
Sep 30, 2021 -7.64 Mn
Jun 30, 2021 -6.64 Mn